Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are Traders Piling Into These 5 Stocks Today?

Fortinet Rallies After Earnings Beat

Fortinet Inc (NASDAQ:FTNT) reported better-than-expected earnings and sales for its first quarter and the company’s shares are 5.7% higher because of it. For the first three months of the year, Fortinet earned an adjusted $0.12 per share on sales of $284.6 million, beating estimates by $0.03 per share and $11.14 million respectively. Sales rocketed up by 33.7% year-over-year while billings grew by 30% year-over-year. Deferred revenue rose to $837.2 million, up from the fourth quarter’s $791.3 million. Cliff Asness‘ AQR Capital Management was a top shareholder of Fortinet Inc (NASDAQ:FTNT) in our database at the end of December.

Follow Fortinet Inc. (NASDAQ:FTNT)
Trade (NASDAQ:FTNT) Now!

Examworks to Sell Itself

Examworks Group, Inc. (NYSE:EXAM) is 5.78% in the green after the company entered into a definitive agreement to be acquired by Leonard Green & Partners, L.P. for $35.05 in cash per share. The transaction is expected to close in the third quarter of this year. ExamWorks’ board of directors has approved the merger agreement and recommends shareholders vote in its favor as well. Examworks also has a 25-business-day period concluding on June 1 to see if it can get a better deal with other companies. Of the 786 active funds that we track, nine of them owned $74.42 million of Examworks Group, Inc. (NYSE:EXAM)’s shares on December 31, which accounted for 6.70% of the float.

Follow Examworks Group Inc. (NYSE:EXAM)
Trade (NYSE:EXAM) Now!

Boston Scientific Soars On Good First Quarter Results

Boston Scientific Corporation (NYSE:BSX) shares have soared by 9% after the company earned $0.28 per share on sales of $1.96 billion in the first quarter, beating the consensus estimates by $0.04 per share in earnings and $50 million in revenue. Revenue jumped by 10.7% year-over-year, led by Boston Scientific’s MedSurg division, which saw sales jump by 25.8%. Second quarter guidance was for GAAP EPS of $0.14-to-$0.17, adjusted EPS of $0.25-$0.27, and sales of $1.927 billion-to-$1.980 billion. For the full 2016 year the company is guiding for GAAP EPS of $0.64-to-$0.69 and adjusted EPS of $1.06-to-$1.10, each of which was up slightly from previous guidance. The number of elite funds in our system with holdings in Boston Scientific Corporation (NYSE:BSX) decreased to 33 from 37 during the fourth quarter.

Follow Boston Scientific Corp (NYSE:BSX)
Trade (NYSE:BSX) Now!

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.